skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
02/01/2011
Application #:
11789154
Filing Dt:
04/24/2007
Publication #:
Pub Dt:
10/25/2007
Inventors:
Jennifer Bolton, Robert S. Chao, Miroslav Rapta, Lisa Williams, Richard D. Wilson
Title:
CRYSTALLINE FORMS OF A DIMETHYLPHENYL COMPOUND
Assignment: 1
Reel/Frame:
019534/0709Recorded: 07/09/2007Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
07/03/2007
Exec Dt:
06/13/2007
Exec Dt:
06/14/2007
Exec Dt:
07/03/2007
Exec Dt:
06/14/2007
Assignee:
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondent:
JEFFREY A. HAGENAH, PH.D.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Assignment: 2
Reel/Frame:
033175/0620Recorded: 06/10/2014Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/31/2014
Assignee:
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA USA 94080
Correspondent:
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Assignment: 3
Reel/Frame:
054393/0695Recorded: 11/12/2020Pages: 18
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/20/2020
Assignee:
901 GATEWAY BLVD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondent:
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO, CA 94080

Search Results as of: 06/20/2024 02:55 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT